Analysis of the progress of Tuberculosis Care Pilot Project

doi:10.19982/j.issn.1000-6621.20250082

Abstract

Abstract:

Objective: To analyze and evaluate the progress of tuberculosis (TB) prevention and treatment in the first 40 pilot counties (districts) of Tuberculosis Care Action Pilot Project. Methods: From April to June 2024, the National Center for Tuberculosis Control and Prevention of China CDC issused unified semi-structured electronic questionnaires to 40 pilot counties (districts) from 15 provinces, to learn the progress for capacity of patient detection, key population TB screening, and implementation of humanistic care measures for TB patients comparing to baseline. Results: In 2023, a total of 11037 pulmonary TB patients were confirmed and registered across the pilot counties (districts), of which 7330 were bacteriologically confirmed, with an overall positivity rate of 66.41% (7330/11037), meeting the 65% target specified for the final evaluation. Among the 562 bacteriologically negative TB cases, 427 met the criteria for a diagnosis of bacteriologically negative TB, with a compliance rate of 75.98% (427/562), falling short of the 90% target specified for the final evaluation. For key population TB screenings, the chest X-ray screening rate among individuals aged ≥65 years and diabetic patients were 22.38% (561911/2510827) and 14.99% (110675/738182), respectively, which were higher than those of baseline period (13.48%, 377436/2800877; 12.27%, 93808/764416). However, these rates were still relative low. In terms of patient management and humanistic care measures, 38 out of the 40 pilot counties (districts) were able to use information technology to manage patients, and all pilot counties (districts) provided full course health education to registered patients. Additonally, nutritional and psychological support were provided in 30 counties (districts), which was three times the number during baseline period (10). Conclusion: Notable progress has been achieved in pilot areas; however, improvement is still needed in the diagnostics of bacteriologically negative pulmonary TB and the screening of key populations.

Key words: Tuberculosis, Pilot projects, Questionnaires

CLC Number:

Wang Yunxia, Meng Qinglin, Zhou Lin, Liu Eryong. Analysis of the progress of Tuberculosis Care Pilot Project[J]. Chinese Journal of Antituberculosis, 2025, 47(8): 986-991. doi: 10.19982/j.issn.1000-6621.20250082

Figures/Tables 4

References 11

[1]	王前, 王嘉, 刘二勇, 等. 《中国结核病患者关怀手册》专家解读. 中国防痨杂志, 2022, 44(1): 49-53. doi:10.19982/j.issn.1000-6621.20210613.
[2]	王云霞, 孟庆琳, 刘二勇, 等. 我国结核病关爱行动试点项目基线调查分析. 中国防痨杂志, 2024, 46 (3): 325-332. doi:10.19982/j.issn.1000-6621.20230359.
[3]	中国防痨协会.T/CHATA 008— 2020 病原学检测阴性肺结核诊断流程. 2020-09-22.
[4]	高孟秋. 《WS 288—2017肺结核诊断》新标准中关于临床诊断患者判定的解析. 中国防痨杂志, 2018, 40(3): 243-246. doi:10.3969/j.issn.1000-6621.2018.03.005.
[5]	周林, 刘二勇. “早诊断及规范治疗肺结核患者”是落实最新国家行业标准及技术规范的精髓. 中国防痨杂志, 2020, 42(9):894-895. doi:10.3969/j.issn.1000-6621.2020.09.002.
[6]	钟引, 何金戈, 李京, 等. 2020年四川省定点医疗机构病原学阴性肺结核诊断质量评估分析. 职业卫生与病伤, 2025, 40(1): 46-50. doi:10.19973/j.cnki.1006-172X.240069.
[7]	王坚杰, 陈军, 徐玲, 等. 武汉市病原学检测阴性肺结核诊断质量分析. 国际检验医学杂志, 2024, 45 (18): 2197-2200, 2206. doi:10.3969/j.issn.1673-4130.2024.18.004.
[8]	郑建莉, 吴语媚, 张仕利, 等. 福建省龙岩市结核病重点高危人群主动筛查成本效果分析. 结核与肺部疾病杂志, 2025, 6(1):35-39. doi:10.19983/j.issn.2096-8493.2024163.
[9]	国家疾控局, 国家卫生健康委, 国家发展改革委, 等. 关于印发《全国结核病防治规划(2024—2030年)》的通知. 国疾控传防发〔2024〕19号.2024-11-28.
[10]	卢春丽, 袁园, 黄亚玲, 等. 营养支持对肺结核患者营养状况和免疫功能的影响. 临床医学研究与实践, 2025, 10(4):49-52. doi:10.19347/j.cnki.2096-1413.202504012.
[11]	常高杰, 张华楠, 赵怡. 基于关爱和支持的护理干预模式在肺结核抗结核治疗中的效果研究. 山西医药杂志, 2024, 53(23):1829-1832. doi:10.3969/j.issn.0253-9926.2024.23.017.

类别	2022年			2023年
类别	病例数 (例)	符合诊断依据的病例数(例)	诊断依据符合率(%)	病例数 (例)	符合诊断依据的病例数(例)	诊断依据符合率(%)
病原学阴性肺结核	734	629	85.69	562	427	75.98
肺组织结核	669	576	86.10	506	383	75.69
气管支气管结核	28	5	17.86	15	14	93.33
结核性胸膜炎	150	90	60.00	87	55	63.22
儿童结核病	3	2	2/3	3	3	3/3

重点人群	2022年			2023年
重点人群	总人数 (名/例)	接受胸片筛查(名/例)	筛查率 (%)	总人数 (名/例)	接受胸片筛查(名/例)	筛查率 (%)
HIV感染者/AIDS患者	17807	17105	96.06	16736	16219	96.91
结核病患者密切接触者	50515	46884	92.81	77664	57911	80.66
≥65岁老年人	2800877	377436	13.48	2510827	561911	22.38
糖尿病患者	764416	93808	12.27	738182	110675	14.99

健康教育方式	病例数 (例)	时长(min)
健康教育方式	病例数 (例)	中位数	最大值	最小值
定点医疗机构	108	15	1800	7
基层医疗卫生机构	50	30	36	25
县(区)结核病预防控制机构	100	60	120	60
定点医疗机构、基层医疗卫生机构	317	60	120	10
定点医疗机构、县(区)级结核病预防控制机构	36	25	27	20
基层医疗卫生机构、县(区)级结核病预防控制机构	91	30	40	30
定点医疗机构、基层医疗卫生机构、县(区)级结核病预防控制机构	1001	60	430	20
合计	1703	60	1800	7

支持类型及方式	病例数(例)	百分率(%)
营养支持	1522	88.64
营养宣教	1494	87.01
营养筛查	1038	60.45
营养监测	645	37.57
营养补助	732	42.63
心理支持	1349	78.57
心理状况测评	1206	89.40
心理健康教育	1117	82.80
心理支持方式
个体	820	60.79
团体	223	16.53
个体和团体	74	5.49
不详	232	17.20

[1]	Fan Jun, Wang Qingya, Wu Chengguo, Lei Rongrong, Zhang Ya, Zhang Ting. Investigation on the psychological and social support status of 445 pulmonary tuberculosis patients in Chongqing metropolitan area [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1007-1013.
[2]	Huang Weiqiang, Liu Xudong, Wang Lili, Chen Xingxing, Shang Huihui, Xu Ya, Hu Ming. Clinical characteristics and treatment outcomes of extracorporeal membrane oxygenation in 13 patients with severe pulmonary tuberculosis-associated acute respiratory distress syndrome [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1014-1022.
[3]	Zhang Ye, Liang Wenwen, Huo Chenchao, Shi Jinghua, Qi Xianglong, Cheng Kai, Lu Yu, Xu Jian. Synergistic effect of zuclopenthixol on the anti-tuberculosis activity of clofazimine and its mechanism of action on MmpL5-MmpS5 [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1023-1030.
[4]	Fan Ruifang, Dai Xiaowei, Yang Xinyu, Chen Shuangshuang, Chen Hao, Yu Lan, Zhao Yanfeng, Li Chuanyou, Wang Nenhan. A study on the identification of Mycobacterium species using fluorescent PCR probe melting curve technique and DNA microarray chip technique [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1031-1037.
[5]	Xue Yu, Guo Shubin, Lei Xuan, Zhang Jing, Li Wensheng, Liu Yan, Li Huan, Liu Zhifeng, Wang Wei, Wen Li. Construction and analysis of early warning and prediction model for risk factors of initially treated severe pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1038-1043.
[6]	Abuduresuli Tu’ersun, Abudukeyoumujiang Abulizi, Patiman Maimaiti, Huang Chencui, Shen Lingyan, Mayidili Nijiati. Predicting pulmonary tuberculosis treatment outcomes using longitudinal chest CT radiomics and deep learning [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1044-1052.
[7]	Jiao Jiahuan, Sun Changfeng, Wu Gang, Huang Fuli, Sheng Yunjian. The value of machine learning algorithm-based diagnostic models in tuberculous pleural effusion [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1053-1061.
[8]	Kong Hanhan, Chen Zijiao, Zeng Jianfeng, Wu Dan, Tang Lin, Wen Min. Development and reliability and validity testing of the Pulmonary Tuberculosis Symptom Cluster Scale [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1062-1067.
[9]	Zhu Qingdong, Zhao Chunyan, Xie Zhouhua, Song Shulin, Song Chang. Research progress on the application of artificial intelligence-based CT radiomics in the diagnosis and treatment response monitoring of tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1068-1076.
[10]	Zhu Qingyu, Liu Jiayun, Long Yin. Advances in the application of extracellular vesicles and the diagnosis of tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 1077-1084.
[11]	Xia Hui, Zhao Yanlin. The potentials and challenges of using tongue swab for Mycobacterium tuberculosis complex detection through nucleic acid amplification tests in the diagnosis and screening of pulmonary tuberculosis [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 976-980.
[12]	Meng Qinglin, Wang Yunxia, Tang Yan, Liu Eryong. Analysis of psychological support of tuberculosis patients at home and abroad [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 981-985.
[13]	Sun Shanhua, Lezhe Laji, Gao Zhidong, Zhao Yao, He Xin, Xu Qiang, Yang Maosheng, Xu Yan. Knowledge, attitude and practice survey on tuberculosis prevention and control among specific populations in Meigu County, Liangshan Yi Autonomous Prefecture, Sichuan Province [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 992-998.
[14]	Tang Lingling, Chen Danping, Li Yuru, Jiang Hua, Huang Le, Su Limin. Analysis of family functioning of patients with drug-resistant pulmonary tuberculosis and its influencing factors [J]. Chinese Journal of Antituberculosis, 2025, 47(8): 999-1006.
[15]	Tuberculosis Control Branch of Chinese Antituberculosis Association, Standardization Professional Branch of Chinese Antituberculosis Association, Elderly Tuberculosis Control Branch of Chinese Antituberculosis Association. Expert consensus on the application of Mycobacterium tuberculosis infection detection technologies [J]. Chinese Journal of Antituberculosis, 2025, 47(7): 813-829.